Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Restless Legs Syndrome”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Large-scale testing (Phase 3)Study completedNCT00498108
What this trial is testing

Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects

Who this might be right for
Idiopathic Restless Legs Syndrome
UCB Pharma 341
Not applicableStudy completedNCT04827329
What this trial is testing

Anesthetic Management of Patients With Chronic Sleep Disorders

Who this might be right for
NarcolepsyIdiopathic HypersomniaRestless Legs Syndrome
University Hospital, Montpellier 700
Post-approval studies (Phase 4)Study completedNCT01455012
What this trial is testing

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB BIOSCIENCES GmbH 81
Testing effectiveness (Phase 2)Study completedNCT00498186
What this trial is testing

Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
UCB Pharma 295
Large-scale testing (Phase 3)Study completedNCT00135993
What this trial is testing

Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB Pharma 811
Not applicableLooking for participantsNCT05321355
What this trial is testing

Mainz Register of Patients With Sleep Disorders

Who this might be right for
Sleep DisorderSleep Disorder ParasomniaNarcolepsy+6 more
Johannes Gutenberg University Mainz 500
Testing effectiveness (Phase 2)Study completedNCT00389831
What this trial is testing

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms

Who this might be right for
Restless Legs Syndrome
UCB Pharma 44
Post-approval studies (Phase 4)Study completedNCT00472199
What this trial is testing

Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 331
Large-scale testing (Phase 3)Study completedNCT00133198
What this trial is testing

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 345
Post-approval studies (Phase 4)Study completedNCT00356096
What this trial is testing

Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances

Who this might be right for
Restless Legs SyndromeDepression
Boehringer Ingelheim 404
Large-scale testing (Phase 3)Study completedNCT01569464
What this trial is testing

Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
UCB Pharma 150
Testing effectiveness (Phase 2)Ended earlyNCT00834327
What this trial is testing

Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
Neurogen Corporation 230
Testing effectiveness (Phase 2)Study completedNCT00239486
What this trial is testing

Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 109
Post-approval studies (Phase 4)Study completedNCT01823770
What this trial is testing

Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome (RLS)
University Hospital, Montpellier 130
Large-scale testing (Phase 3)Study completedNCT00357097
What this trial is testing

The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

Who this might be right for
Restless Legs SyndromeModerate to Severe Idiopathic Restless Legs Syndrome (RLS)
GlaxoSmithKline 240
Testing effectiveness (Phase 2)Study completedNCT02231918
What this trial is testing

Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 26
Post-approval studies (Phase 4)Study completedNCT00375284
What this trial is testing

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 404
Not applicableStudy completedNCT01386944
What this trial is testing

Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation

Who this might be right for
Restless Legs Syndrome
UCB Pharma 102
Large-scale testing (Phase 3)Study completedNCT01112644
What this trial is testing

Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms

Who this might be right for
Moderate to Severe Idiopathic RLS With Daytime Symptoms
Mundipharma Research GmbH & Co KG 205
Large-scale testing (Phase 3)Study completedNCT00390689
What this trial is testing

A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.

Who this might be right for
Idiopathic Restless Legs Syndrome
Boehringer Ingelheim 154
Load More Results